Barclays PLC
20 April 2005
20 April 2005
Notification of directors' interests: Companies Act 1985 s.329
The independent trustee of the Barclays Group (ESAS) Employees' Benefit Trust
(the 'ESAS Trust') notified the Company on 19 April 2005 that it had between 11
April 2005 and 15 April 2005 exercised its discretion and released a total of
80,250 ordinary shares in Barclays PLC and on 15 April 2005 it purchased 209,908
ordinary shares in Barclays PLC at a price of 557.50p per share. None of the
shares released or purchased were in respect of an award made to a director of
Barclays PLC.
Following these transactions, the trustees of all the Barclays Group employees'
benefit trusts hold a total of 133,202,160 ordinary shares in Barclays PLC.
Matthew W Barrett, Chairman, and the executive directors of Barclays are amongst
the potential beneficiaries under these trusts and are therefore regarded for
Companies Act purposes as being interested in the Barclays PLC ordinary shares
held in them.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.